Drug resistance has long turned some of the most advanced lung cancer therapies into temporary victories, with tumors ...

CRISPR screens often mislead cancer research because bacterial Cas9 components trigger immune reactions in mice. ETH Zurich ...

The first gene-editing therapies for HIV/Aids are entering trials but the virus is proving once again that it is a master at ...

CRISPR Therapeutics AG (NASDAQ:CRSP) is one of the best gene-editing stocks to buy according to hedge funds. On November 11, ...

A breakthrough study has just supercharged Fusarium venenatum (the fungus used in mycoprotein products like Quorn), turning ...

This study presents a comprehensive benchmarking of human-derived transcription activation domains (hTADs) for use in CRISPR-based artificial ...

In a landmark moment for Indian science, Union Minister of State (Independent Charge) for Science & Technology Dr Jitendra ...

Seek Labs on November 17 announced the publication of a peer-reviewed paper in Viruses (MDPI), revealing the first successful ...

Cleveland Clinic researchers have discovered they may be able to shut off the cholesterol gene. Michigan couple charged with ...

A new study shows that neurons repair CRISPR-Cas9 cuts in unique, highly predictable ways, unlike dividing cells. Researchers ...

Sickle Cell Disease, a severe genetic blood disorder, disproportionately affects India’s tribal population, particularly in ...

ToolGen (KOSDAQ: 199800; CEO Jong-sang Ryu), a leader in genome editing technology, announced that the United States Patent ...